Treatment of acute HCV infection with direct acting antivirals (DAA) in HIV patients

被引：0
|
作者：
Gomez-Ayerbe, C. [1 ,2 ]
Palacios, R. [1 ,2 ]
Perez, C. [1 ,2 ]
Tellez, F. [3 ]
Sayago, C. [4 ]
Rios, M. J. [5 ]
Martin-Aspas, A. [6 ]
Camacho, A. [7 ]
Munoz, L. [8 ]
Santos, J. [1 ,2 ]
机构：
[1] Hosp Univ Virgen Victoria, Malaga, Spain
[2] Inst Invest Biomed Malaga IBIMA, Malaga, Spain
[3] Hosp Univ Puerto Real, Puerto Real, Spain
[4] Hosp Univ Virgen Valme, Seville, Spain
[5] Hosp Univ Virgen Macarena, Seville, Spain
[6] Hosp Univ Puerta Mar, Cadiz, Spain
[7] Hosp Univ Reina Sofia, Cordoba, Spain
[8] Hosp Univ San Cecilio, Granada, Spain
来源：
HIV MEDICINE | 2019年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
PE37/23
引用
收藏
页码：298 / 298
页数：1
相关论文
共 50 条
  • [1] Treatment of acute HCV infection with direct acting antivirals (DAA) in HIV patients
    Gomez-Ayerbe, C.
    Palacios, R.
    Tellez, F.
    Sayago, C.
    Rios, M.
    Martin-Aspas, A.
    Camacho, A.
    Munoz, L.
    Santos, J.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
  • [2] Survival of HIV/HCV co-infected patients before introduction of HCV direct acting antivirals (DAA)
    Dold, L.
    Schwarze-Zander, C.
    Boesecke, C.
    Mohr, R.
    Langhans, B.
    Wasmuth, J-C
    Strassburg, C. P.
    Rockstroh, J. K.
    Spengler, U.
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [3] Survival of HIV/HCV co-infected patients before introduction of HCV direct acting antivirals (DAA)
    L. Dold
    C. Schwarze-Zander
    C. Boesecke
    R. Mohr
    B. Langhans
    J.-C. Wasmuth
    C. P. Strassburg
    J. K. Rockstroh
    U. Spengler
    [J]. Scientific Reports, 9
  • [4] Peritransplant treatment with Direct Acting Antivirals of HIV-HCV coinfected patients
    Vinaixa, Carmen
    Aguilera, Victoria
    Rubin, Angel
    Garcia, Maria
    Blanes, Marino
    Benlloch, Salvador
    Prieto, Martin
    Berenguer, Marina
    Juan, Fernando San
    [J]. HEPATOLOGY, 2016, 64 : 807A - 808A
  • [5] Treatment of HCV in the Department of Corrections (DOC) in the era of Oral Direct Acting Antivirals (DAA)
    Sterling, Richard K.
    Cherian, Reena
    Shawn, Lewis
    Chhatrala, Ravi
    Alsaleh, Anas
    Genther, Kathleen
    Driscoll, Carloyn
    Martin, Kelly
    Matherly, Scott C.
    Siddiqui, Mohammad
    Luketic, Velimir A.
    Stravitz, R. Todd
    Puri, Puneet
    Lee, Hannah
    Smith, Paula G.
    Sanyal, Arun J.
    [J]. HEPATOLOGY, 2016, 64 : 438A - 439A
  • [6] Advances in the treatment of chronic HCV infection with direct acting antivirals
    Sulkowski, Mark
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2017, 74 : 67 - 67
  • [7] Liver fibrosis evolution after hepatitis C treatment with direct acting antivirals (DAA) in co-infected patients HCV/HIV
    Mendez, J.
    Videira Santos, F.
    Cipriano, A.
    Soeiro, C.
    Valdoleiros, S.
    Goncalves, C.
    Tavares, A. P.
    Castro, R. Sarmento E.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2018, 73 : 241 - 241
  • [8] Treatment of cirrhotic monoinfected and HCV/HIV coinfected patients with direct acting antivirals (DAAs)
    Santos, F. Videira
    Cipriano, A.
    Valdoleiros, S.
    Tavares, A. P.
    Horta, A.
    Mendez, J.
    Vasconcelos, O.
    Seabra, J.
    Abreu, M. A.
    Goncalves, M. J.
    Santos, M. J.
    Sarmento-Castro, R.
    [J]. HIV MEDICINE, 2019, 20 : 303 - 304
  • [9] Short duration of direct-acting antivirals for acute HCV infection
    Yu, Ming-Lung
    [J]. LANCET INFECTIOUS DISEASES, 2017, 17 (05): : 481 - 482
  • [10] Timing of treatment initiation of direct-acting antivirals for HIV/HCV coinfected and HCV monoinfected patients
    Rice, Donald P.
    Ordoveza, Michelle A.
    Palmer, Ann M.
    Wu, George Y.
    Chirch, Lisa M.
    [J]. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2018, 30 (12): : 1507 - 1511
12345